Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 602,581	$ 574,885
Costs and expenses:
Cost of revenue	170,926	146,070
Research and development	266,346	195,548
Sales and marketing	201,131	173,953
General and administrative	207,864	62,979
Total costs and expenses	846,267	578,550
Loss from operations	(243,686)	(3,665)
Interest income (expense), net	24,901	712
Other income (expense), net	322	(1,200)
Loss before provision for (benefit from) income taxes	(218,463)	(4,153)
Provision for (benefit from) income taxes	(9,884)	1,128
Net loss	$ (208,579)	$ (5,281)
Net loss per share, basic (in dollars per share)	$ (0.31)	$ (0.01)
Net loss per share, diluted (in dollars per share)	$ (0.31)	$ (0.01)
Weighted-average shares used in computing net loss per share, basic (in shares)	681,140	656,899
Weighted-average shares used in computing net loss per share, diluted (in shares)	681,140	656,899